# Liposomal Bupivacaine vs Bupivacaine for Pain Control After Sternotomy

> **NCT04585867** · PHASE1 · UNKNOWN · sponsor: **University of Kansas Medical Center** · enrollment: 80 (estimated)

## Conditions studied

- Pain Management
- Sternotomy

## Interventions

- **DRUG:** Exparel
- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT04585867
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-11
- **Primary completion:** 2023-10-10
- **Final completion:** 2023-10-10
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2020-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04585867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04585867, "Liposomal Bupivacaine vs Bupivacaine for Pain Control After Sternotomy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04585867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*